​​​​​​​Ono Pharma Breakthrough Science Initiative Award: Harvard Pre-Proposal Deadline

Date: 

Monday, January 10, 2022, 12:00pm


Ono Pharma Breakthrough Science Initiative Award
Harvard Pre-Proposal Deadline: January 10, 2022 by 12:00 PM
Sponsor LOI Deadline (if nominated): February 17, 2022
Award Amount: $300,000/year for up to 3 years and an additional 15% ($45,000) per year for indirect costs

The Breakthrough Science Initiative Awards Program accepts proposals from Principal Investigators involved in original research of Chemical Biology. Chemical Biology is defined as research that deals with the interface between chemistry and biology. The criteria for this field are deliberately broad so as not to disqualify potentially innovative and groundbreaking projects. To be eligible, the PI must be a junior or mid-career scientist within 15 years of starting an independent academic position. Parental leave will be considered in calculating eligibility. The PI may not already be engaged in other sponsored research with Ono Pharmaceutical Co., Ltd. and/or other grant programs with the Ono Pharma Foundation. The PI may not apply for funding to amplify current work. However, PIs may research a new idea based on a prior finding.

Recent recipients include Brian Liau (2019, CCB) and Christina Woo (2018, CCB).

This is a limited submission opportunity and Harvard University may submit only two proposals. Applicants for the Harvard nomination must submit a pre-proposal to an internal competition administered by the Office of the Vice Provost of Research via the link above no later than 12 PM on January 10, 2022. Ono Pharmaceutical will accept separate nominations from The Broad Institute of MIT and Harvard, and Beth Israel Deaconess Medical Center. Applicants from these institutions should not apply through the OVPR facilitated process.